{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:04:32Z","timestamp":1787162672239,"version":"build-2736575974"},"reference-count":45,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Although aspirin usage may be associated with a decreased risk of rupture of cerebral aneurysms, any potential therapeutic benefit from aspirin must be weighed against the theoretical risk of greater hemorrhage volume if subarachnoid hemorrhage (SAH) occurs. However, few studies have evaluated the association between prehemorrhage aspirin use and outcomes. This is the first nationwide analysis to evaluate the impact of long-term aspirin and anticoagulant use on outcomes after SAH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Data from the Nationwide Inpatient Sample (NIS; 2006\u20132011) were extracted. Patients with a primary diagnosis of SAH who underwent microsurgical or endovascular aneurysm repair were included; those with a diagnosis of an arteriovenous malformation were excluded. Multivariable logistic regression was performed to calculate the adjusted odds of in-hospital mortality, a nonroutine discharge (any discharge other than to home), or a poor outcome (death, discharge to institutional care, tracheostomy, or gastrostomy) for patients with long-term aspirin or anticoagulant use. Multivariable linear regression was used to evaluate length of hospital stay. Covariates included patient age, sex, comorbidities, primary payer, NIS-SAH severity scale, intracerebral hemorrhage, cerebral edema, herniation, modality of aneurysm repair, hospital bed size, and whether the hospital was a teaching hospital. Subgroup analyses exclusively evaluated patients treated surgically or endovascularly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The study examined 11,549 hospital admissions. Both aspirin (2.1%, n = 245) and anticoagulant users (0.9%, n = 108) were significantly older and had a greater burden of comorbid disease (p &lt; 0.001); severity of SAH was slightly lower in those with long-term aspirin use (p = 0.03). Neither in-hospital mortality (13.5% vs 12.6%) nor total complication rates (79.6% vs 80.0%) differed significantly by long-term aspirin use. Additionally, aspirin use was associated with decreased odds of a cardiac complication (OR 0.57, 95% CI 0.36%\u20130.91%, p = 0.02) or of venous thromboembolic events (OR 0.53, 95% CI 0.30%\u20130.94%, p = 0.03). Length of stay was significantly shorter (15 days vs 17 days [12.73%], 95% CI 5.22%\u201320.24%, p = 0.001), and the odds of a nonroutine discharge were lower (OR 0.63, 95% CI 0.48%\u20130.83%, p = 0.001) for aspirin users. In subgroup analyses, the benefits of aspirin were primarily noted in patients who underwent coil embolization; likewise, among patients treated endovascularly, the adjusted odds of a poor outcome were lower among long-term aspirin users (31.8% vs 37.4%, OR 0.63, 95% CI 0.42%\u20130.94%, p = 0.03). Although the crude rates of in-hospital mortality (19.4% vs 12.6%) and poor outcome (53.6% vs 37.6%) were higher for long-term anticoagulant users, in multivariable logistic regression models these variations were not significantly different (mortality: OR 1.36, 95% CI 0.89%\u20132.07%, p = 0.16; poor outcome: OR 1.09, 95% CI 0.69%\u20131.73%, p = 0.72).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>In this nationwide study, neither long-term aspirin nor anticoagulant use were associated with differential mortality or complication rates after SAH. Aspirin use was associated with a shorter hospital stay and lower rates of nonroutine discharge, with these benefits primarily observed in patients treated endovascularly.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2015.12.jns151107","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T20:56:58Z","timestamp":1460149018000},"page":"537-547","source":"Crossref","is-referenced-by-count":36,"title":["The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis"],"prefix":"10.3171","volume":"126","author":[{"given":"Hormuzdiyar H.","family":"Dasenbrock","sequence":"first","affiliation":[{"name":"Cushing Neurosurgical Outcomes Center,"},{"name":"Department of Neurological Surgery, Brigham and Women's Hospital,"},{"name":"Harvard Medical School, and"},{"name":"H.T. Chan Harvard School of Public Health, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra C.","family":"Yan","sequence":"additional","affiliation":[{"name":"Cushing Neurosurgical Outcomes Center,"},{"name":"Department of Neurological Surgery, Brigham and Women's Hospital,"},{"name":"Warren Alpert School of Medicine, Brown University, Providence, Rhode Island; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Gross","sequence":"additional","affiliation":[{"name":"Barrow Neurological Institute, Division of Neurological Surgery, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donovan","family":"Guttieres","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Brigham and Women's Hospital,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Gormley","sequence":"additional","affiliation":[{"name":"Cushing Neurosurgical Outcomes Center,"},{"name":"Department of Neurological Surgery, Brigham and Women's Hospital,"},{"name":"Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai U.","family":"Frerichs","sequence":"additional","affiliation":[{"name":"Cushing Neurosurgical Outcomes Center,"},{"name":"Department of Neurological Surgery, Brigham and Women's Hospital,"},{"name":"Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ali Aziz-Sultan","sequence":"additional","affiliation":[{"name":"Cushing Neurosurgical Outcomes Center,"},{"name":"Department of Neurological Surgery, Brigham and Women's Hospital,"},{"name":"Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Du","sequence":"additional","affiliation":[{"name":"Cushing Neurosurgical Outcomes Center,"},{"name":"Department of Neurological Surgery, Brigham and Women's Hospital,"},{"name":"Harvard Medical School, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns151107","series-title":"J Neurointerv Surg","article-title":"Evaluation of time to aneurysm treatment following subarachnoid hemorrhage: comparison of patients treated with clipping versus coiling","author":"Attenello FJ,","year":"2015","unstructured":"Attenello FJ, Reid P, Wen T, Cen S, Kim-Tenser M, Sanossian N, : Evaluation of time to aneurysm treatment following subarachnoid hemorrhage: comparison of patients treated with clipping versus coiling. J Neurointerv Surg [epub ahead of print]201525765950"},{"key":"b2-jns151107","series-title":"Ann Biomed Eng","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s10439-009-9794-y","article-title":"Wall shear stress and pressure distribution on aneurysms and infundibulae in the posterior communicating artery bifurcation","volume":"37","author":"Baek H,","year":"2009","unstructured":"Baek H, Jayaraman MV, Karniadakis GE: Wall shear stress and pressure distribution on aneurysms and infundibulae in the posterior communicating artery bifurcation. Ann Biomed Eng 37:2469\u20132487, 20091975705810.1007\/s10439-009-9794-y"},{"key":"b3-jns151107","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1227\/NEU.0000000000000164","article-title":"In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996\u20132000: the effect of hospital and surgeon volume","volume":"52","author":"Barker FG II,","year":"2003","unstructured":"Barker FG II, Amin-Hanjani S, Butler WE, Ogilvy CS, Carter BS: In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996\u20132000: the effect of hospital and surgeon volume. Neurosurgery 52:995\u20131009, 20031269954010.1227\/NEU.0000000000000164"},{"key":"b4-jns151107","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3171\/2013.8.JNS13228","article-title":"Predicting inpatient complications from cerebral aneurysm clipping: the Nationwide Inpatient Sample 2005\u20132009","volume":"120","author":"Bekelis K,","year":"2014","unstructured":"Bekelis K, Missios S, MacKenzie TA, Desai A, Fischer A, Labropoulos N, : Predicting inpatient complications from cerebral aneurysm clipping: the Nationwide Inpatient Sample 2005\u20132009. J Neurosurg 120:591\u2013598, 201410.3171\/2013.8.JNS1322824032701"},{"key":"b5-jns151107","series-title":"Am J Med","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.amjmed.2007.10.002","article-title":"Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis","volume":"121","author":"Berger JS,","year":"2008","unstructured":"Berger JS, Brown DL, Becker RC: Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. Am J Med 121:43\u201349, 20081818707210.1016\/j.amjmed.2007.10.002"},{"key":"b6-jns151107","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3174\/ajnr.A3321","article-title":"Age-related trends in the treatment and outcomes of ruptured cerebral aneurysms: a study of the Nationwide Inpatient Sample 2001\u20132009","volume":"34","author":"Brinjikji W,","year":"2013","unstructured":"Brinjikji W, Lanzino G, Rabinstein AA, Kallmes DF, Cloft HJ: Age-related trends in the treatment and outcomes of ruptured cerebral aneurysms: a study of the Nationwide Inpatient Sample 2001\u20132009. AJNR Am J Neuroradiol 34:1022\u20131027, 201310.3174\/ajnr.A332123124637"},{"key":"b7-jns151107","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"E147","DOI":"10.1016\/j.wneu.2014.02.030","article-title":"Aspirin for prevention of subarachnoid hemorrhage: the stage is set for a randomized controlled trial","volume":"74","author":"Chalouhi N,","year":"2014","unstructured":"Chalouhi N, Jabbour P, Hasan D, Starke RM: Aspirin for prevention of subarachnoid hemorrhage: the stage is set for a randomized controlled trial. Neurosurgery 74:E147\u2013E148, 201410.1016\/j.wneu.2014.02.030"},{"key":"b8-jns151107","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1227\/NEU.0000000000000164","article-title":"Aspirin for prophylaxis against cerebral aneurysm rupture","volume":"81","author":"Chalouhi N,","year":"2014","unstructured":"Chalouhi N, Jabbour P, Starke RM, Hasan DM: Aspirin for prophylaxis against cerebral aneurysm rupture. World Neurosurg 81:e2\u2013e3, 201410.1227\/NEU.0000000000000164"},{"key":"b9-jns151107","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/00006123-199911000-00024","article-title":"Inflammation and intracranial aneurysms","volume":"45","author":"Chyatte D,","year":"1999","unstructured":"Chyatte D, Bruno G, Desai S, Todor DR: Inflammation and intracranial aneurysms. Neurosurgery 45:1137\u20131147, 199910.1097\/00006123-199911000-0002410549930"},{"key":"b10-jns151107","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1227\/01.neu.0000279724.05898.e7","article-title":"Generalized convulsive status epilepticus after nontraumatic subarachnoid hemorrhage: the Nationwide Inpatient Sample","volume":"61","author":"Claassen J,","year":"2007","unstructured":"Claassen J, Bateman BT, Willey JZ, Inati S, Hirsch LJ, Mayer SA, : Generalized convulsive status epilepticus after nontraumatic subarachnoid hemorrhage: the Nationwide Inpatient Sample. Neurosurgery 61:60\u201365, 200710.1227\/01.neu.0000279724.05898.e717621019"},{"key":"b11-jns151107","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3171\/2008.11.JNS081038","article-title":"Influence of weekend versus weekday hospital admission on mortality following subarachnoid hemorrhage. Clinical article","volume":"111","author":"Crowley RW,","year":"2009","unstructured":"Crowley RW, Yeoh HK, Stukenborg GJ, Ionescu AA, Kassell NF, Dumont AS: Influence of weekend versus weekday hospital admission on mortality following subarachnoid hemorrhage. Clinical article. J Neurosurg 111:60\u201366, 20091923192810.3171\/2008.11.JNS081038"},{"key":"b12-jns151107","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1161\/01.STR.0000083621.44269.3E","article-title":"Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review","volume":"34","author":"Dorhout Mees SM,","year":"2003","unstructured":"Dorhout Mees SM, Rinkel GJ, Hop JW, Algra A, van Gijn J: Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review. Stroke 34:2285\u20132289, 200310.1161\/01.STR.0000083621.44269.3E"},{"issue":"4","key":"b13-jns151107","series-title":"Cochrane Database Syst Rev","first-page":"CD006184","article-title":"Antiplatelet therapy for aneurysmal subarachnoid haemorrhage","author":"Dorhout Mees SM,","year":"2007","unstructured":"Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ: Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 4CD006184, 2007"},{"key":"b14-jns151107","series-title":"Med Care","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser A,","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM: Comorbidity measures for use with administrative data. Med Care 36:8\u201327, 1998943132810.1097\/00005650-199801000-00004"},{"key":"b15-jns151107","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3171\/2013.7.JNS13595","article-title":"The prevalence of patient safety indicators and hospital-acquired conditions in patients with ruptured cerebral aneurysms: establishing standard performance measures using the Nationwide Inpatient Sample database","volume":"119","author":"Fargen KM,","year":"2013","unstructured":"Fargen KM, Neal D, Rahman M, Hoh BL: The prevalence of patient safety indicators and hospital-acquired conditions in patients with ruptured cerebral aneurysms: establishing standard performance measures using the Nationwide Inpatient Sample database. J Neurosurg 119:1633\u20131640, 20132399189910.3171\/2013.7.JNS13595"},{"key":"b16-jns151107","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1227\/01.NEU.0000197332.55054.C8","article-title":"Growth factor receptor expression and remodeling of saccular cerebral artery aneurysm walls: implications for biological therapy preventing rupture","volume":"58","author":"Fr\u00f6sen J,","year":"2006","unstructured":"Fr\u00f6sen J, Piippo A, Paetau A, Kangasniemi M, Niemel\u00e4 M, Hernesniemi J, : Growth factor receptor expression and remodeling of saccular cerebral artery aneurysm walls: implications for biological therapy preventing rupture. Neurosurgery 58:534\u2013541, 200610.1227\/01.NEU.0000197332.55054.C816528195"},{"key":"b17-jns151107","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1161\/01.STR.0000140636.30204.da","article-title":"Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases","volume":"35","author":"Fr\u00f6sen J,","year":"2004","unstructured":"Fr\u00f6sen J, Piippo A, Paetau A, Kangasniemi M, Niemel\u00e4 M, Hernesniemi J, : Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke 35:2287\u20132293, 200410.1161\/01.STR.0000140636.30204.da15322297"},{"key":"b18-jns151107","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1161\/STROKEAHA.111.000811","article-title":"Risk of subarachnoid hemorrhage and early case fatality associated with outpatient antithrombotic drug use","volume":"44","author":"Garbe E,","year":"2013","unstructured":"Garbe E, Kreisel SH, Behr S: Risk of subarachnoid hemorrhage and early case fatality associated with outpatient antithrombotic drug use. Stroke 44:2422\u20132426, 20132381398610.1161\/STROKEAHA.111.000811"},{"key":"b19-jns151107","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/WNL.0b013e31829e6ffa","article-title":"Antithrombotic drugs and risk of hemorrhagic stroke in the general population","volume":"81","author":"Garc\u00eda-Rodr\u00edguez LA,","year":"2013","unstructured":"Garc\u00eda-Rodr\u00edguez LA, Gaist D, Morton J, Cookson C, Gonz\u00e1lez-P\u00e9rez A: Antithrombotic drugs and risk of hemorrhagic stroke in the general population. Neurology 81:566\u2013574, 201310.1212\/WNL.0b013e31829e6ffa23843464"},{"key":"b20-jns151107","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.wneu.2013.03.072","article-title":"Aspirin and aneurysmal subarachnoid hemorrhage","volume":"82","author":"Gross BA,","year":"2014","unstructured":"Gross BA, Rosalind Lai PM, Frerichs KU, Du R: Aspirin and aneurysmal subarachnoid hemorrhage. World Neurosurg 82:1127\u20131130, 20142354884710.1016\/j.wneu.2013.03.072"},{"key":"b21-jns151107","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1161\/STROKEAHA.111.619411","article-title":"Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture","volume":"42","author":"Hasan DM,","year":"2011","unstructured":"Hasan DM, Mahaney KB, Brown RD Jr, Meissner I, Piepgras DG, Huston J, : Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke 42:3156\u20133162, 20112198020810.1161\/STROKEAHA.111.619411"},{"key":"b22-jns151107","series-title":"Arch Intern Med","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1001\/archinte.164.1.40","article-title":"Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses","volume":"164","author":"Hennekens CH,","year":"2004","unstructured":"Hennekens CH, Sacks FM, Tonkin A, Jukema JW, Byington RP, Pitt B, : Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses. Arch Intern Med 164:40\u201344, 20041471832010.1001\/archinte.164.1.40"},{"key":"b23-jns151107","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/STROKEAHA.109.569269","article-title":"Length of stay and total hospital charges of clipping versus coiling for ruptured and unruptured adult cerebral aneurysms in the Nationwide Inpatient Sample database 2002 to 2006","volume":"41","author":"Hoh BL,","year":"2010","unstructured":"Hoh BL, Chi YY, Lawson MF, Mocco J, Barker FG II: Length of stay and total hospital charges of clipping versus coiling for ruptured and unruptured adult cerebral aneurysms in the Nationwide Inpatient Sample database 2002 to 2006. Stroke 41:337\u2013342, 201010.1161\/STROKEAHA.109.569269"},{"key":"b24-jns151107","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.wneu.2011.05.054","article-title":"Incidence of ventricular shunt placement for hydrocephalus with clipping versus coiling for ruptured and unruptured cerebral aneurysms in the Nationwide Inpatient Sample database: 2002 to 2007","volume":"76","author":"Hoh BL,","year":"2011","unstructured":"Hoh BL, Kleinhenz DT, Chi YY, Mocco J, Barker FG II: Incidence of ventricular shunt placement for hydrocephalus with clipping versus coiling for ruptured and unruptured cerebral aneurysms in the Nationwide Inpatient Sample database: 2002 to 2007. World Neurosurg 76:548\u2013554, 201110.1016\/j.wneu.2011.05.054"},{"key":"b25-jns151107","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1227\/NEU.0b013e31821bc46d","article-title":"Incidence of seizures or epilepsy after clipping or coiling of ruptured and unruptured cerebral aneurysms in the Nationwide Inpatient Sample database: 2002\u20132007","volume":"69","author":"Hoh BL,","year":"2011","unstructured":"Hoh BL, Nathoo S, Chi YY, Mocco J, Barker FG II: Incidence of seizures or epilepsy after clipping or coiling of ruptured and unruptured cerebral aneurysms in the Nationwide Inpatient Sample database: 2002\u20132007. Neurosurgery 69:644\u2013650, 20112149915510.1227\/NEU.0b013e31821bc46d"},{"key":"b26-jns151107","series-title":"AJNR Am J Neuroradiol","first-page":"1409","article-title":"In-hospital morbidity and mortality after endovascular treatment of unruptured intracranial aneurysms in the United States, 1996\u20132000: effect of hospital and physician volume","volume":"24","author":"Hoh BL,","year":"2003","unstructured":"Hoh BL, Rabinov JD, Pryor JC, Carter BS, Barker FG II: In-hospital morbidity and mortality after endovascular treatment of unruptured intracranial aneurysms in the United States, 1996\u20132000: effect of hospital and physician volume. AJNR Am J Neuroradiol 24:1409\u20131420, 200312917139"},{"key":"b27-jns151107","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1212\/WNL.54.4.872","article-title":"Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage","volume":"54","author":"Hop JW,","year":"2000","unstructured":"Hop JW, Rinkel GJ, Algra A, Berkelbach van der Sprenkel JW, van Gijn J: Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage. Neurology 54:872\u2013878, 20001069097910.1212\/WNL.54.4.872"},{"key":"b28-jns151107","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1161\/01.STR.30.9.1764","article-title":"Prospective study of aspirin use and risk of stroke in women","volume":"30","author":"Iso H,","year":"1999","unstructured":"Iso H, Hennekens CH, Stampfer MJ, Rexrode KM, Colditz GA, Speizer FE, : Prospective study of aspirin use and risk of stroke in women. Stroke 30:1764\u20131771, 199910.1161\/01.STR.30.9.176410471421"},{"key":"b29-jns151107","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3171\/jns.1995.82.6.0945","article-title":"Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"82","author":"Juvela S:","year":"1995","unstructured":"Juvela S: Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg 82:945\u2013952, 1995776019610.3171\/jns.1995.82.6.0945"},{"key":"b30-jns151107","series-title":"J Clin Neurosci","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jocn.2013.07.003","article-title":"Incidence and risk factors associated with in-hospital venous thromboembolism after aneurysmal subarachnoid hemorrhage","volume":"21","author":"Kshettry VR,","year":"2014","unstructured":"Kshettry VR, Rosenbaum BP, Seicean A, Kelly ML, Schiltz NK, Weil RJ: Incidence and risk factors associated with in-hospital venous thromboembolism after aneurysmal subarachnoid hemorrhage. J Clin Neurosci 21:282\u2013286, 201410.1016\/j.jocn.2013.07.00324128773"},{"key":"b31-jns151107","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3171\/2011.8.JNS11324","article-title":"Impact of admission month and hospital teaching status on outcomes in subarachnoid hemorrhage: evidence against the July effect","volume":"116","author":"McDonald RJ,","year":"2012","unstructured":"McDonald RJ, Cloft HJ, Kallmes DF: Impact of admission month and hospital teaching status on outcomes in subarachnoid hemorrhage: evidence against the July effect. J Neurosurg 116:157\u2013163, 201210.3171\/2011.8.JNS1132421942725"},{"key":"b32-jns151107","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1161\/01.STR.27.4.756","article-title":"Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen?","volume":"27","author":"Patrono C,","year":"1996","unstructured":"Patrono C, Roth GJ: Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen?. Stroke 27:756\u2013760, 199610.1161\/01.STR.27.4.7568614944"},{"key":"b33-jns151107","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/01.STR.28.1.6","article-title":"Outcome of aneurysmal subarachnoid hemorrhage in patients on anticoagulant treatment","volume":"28","author":"Rinkel GJ,","year":"1997","unstructured":"Rinkel GJ, Prins NE, Algra A: Outcome of aneurysmal subarachnoid hemorrhage in patients on anticoagulant treatment. Stroke 28:6\u20139, 199710.1161\/01.STR.28.1.68996479"},{"key":"b34-jns151107","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/STROKEAHA.112.672451","article-title":"Effect of low-dose aspirin on functional outcome from cerebral vascular events in women","volume":"44","author":"Rist PM,","year":"2013","unstructured":"Rist PM, Buring JE, Kase CS, Kurth T: Effect of low-dose aspirin on functional outcome from cerebral vascular events in women. Stroke 44:432\u2013436, 201310.1161\/STROKEAHA.112.67245123306328"},{"key":"b35-jns151107","series-title":"J Thromb Haemost","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/j.1538-7836.2010.03856.x","article-title":"Antiplatelet drugs and risk of subarachnoid hemorrhage: a population-based case-control study","volume":"8","author":"Schmidt M,","year":"2010","unstructured":"Schmidt M, Johansen MB, Lash TL, Christiansen CF, Christensen S, S\u00f8rensen HT: Antiplatelet drugs and risk of subarachnoid hemorrhage: a population-based case-control study. J Thromb Haemost 8:1468\u20131474, 20102034572810.1111\/j.1538-7836.2010.03856.x"},{"key":"b36-jns151107","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3171\/2011.1.JNS101528","article-title":"Geographic variation and regional trends in adoption of endovascular techniques for cerebral aneurysms","volume":"114","author":"Smith GA,","year":"2011","unstructured":"Smith GA, Dagostino P, Maltenfort MG, Dumont AS, Ratliff JK: Geographic variation and regional trends in adoption of endovascular techniques for cerebral aneurysms. J Neurosurg 114:1768\u20131777, 201110.3171\/2011.1.JNS10152821314274"},{"key":"b37-jns151107","series-title":"Ann Intern Med","doi-asserted-by":"publisher","first-page":"379","DOI":"10.7326\/0003-4819-150-6-200903170-00006","article-title":"Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding","volume":"150","author":"Steinhubl SR,","year":"2009","unstructured":"Steinhubl SR, Bhatt DL, Brennan DM, Montalescot G, Hankey GJ, Eikelboom JW, : Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding. Ann Intern Med 150:379\u2013386, 20091929307110.7326\/0003-4819-150-6-200903170-00006"},{"key":"b38-jns151107","series-title":"J Neurointerv Surg","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/neurintsurg-2012-010359","article-title":"The safety of anticoagulation in patients with intracranial aneurysms","volume":"5","author":"Tarlov N,","year":"2013","unstructured":"Tarlov N, Norbash AM, Nguyen TN: The safety of anticoagulation in patients with intracranial aneurysms. J Neurointerv Surg 5:405\u2013409, 20132267913010.1136\/neurintsurg-2012-010359"},{"key":"b39-jns151107","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3171\/jns.2004.101.6.0921","article-title":"Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage","volume":"101","author":"Toussaint LG III,","year":"2004","unstructured":"Toussaint LG III, Friedman JA, Wijdicks EF, Piepgras DG, Pichelmann MA, McIver JI, : Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage. J Neurosurg 101:921\u2013925, 200410.3171\/jns.2004.101.6.092115597751"},{"key":"b40-jns151107","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1161\/STROKEAHA.111.626762","article-title":"Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture","volume":"42","author":"Tymianski M:","year":"2011","unstructured":"Tymianski M: Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke 42:3003\u20133004, 201110.1161\/STROKEAHA.111.62676221980203"},{"key":"b41-jns151107","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1161\/01.STR.0000236841.16055.0f","article-title":"Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study","volume":"37","author":"van den Bergh WM,","year":"2006","unstructured":"van den Bergh WM, Algra A, Dorhout Mees SM, van Kooten F, Dirven CM, van Gijn J, : Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study. Stroke 37:2326\u20132330, 200610.1161\/01.STR.0000236841.16055.0f"},{"key":"b42-jns151107","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/STROKEAHA.108.528802","article-title":"Effect of antiplatelet therapy for endovascular coiling in aneurysmal subarachnoid hemorrhage","volume":"40","author":"van den Bergh WM,","year":"2009","unstructured":"van den Bergh WM, Kerr RS, Algra A, Rinkel GJ, Molyneux AJ: Effect of antiplatelet therapy for endovascular coiling in aneurysmal subarachnoid hemorrhage. Stroke 40:1969\u20131972, 200910.1161\/STROKEAHA.108.528802"},{"key":"b43-jns151107","series-title":"World Neurosurg","first-page":"e235","article-title":"Acute lung injury in patients with subarachnoid hemorrhage: a Nationwide Inpatient Sample study","volume":"82","author":"Veeravagu A,","year":"2014","unstructured":"Veeravagu A, Chen YR, Ludwig C, Rincon F, Maltenfort M, Jallo J, : Acute lung injury in patients with subarachnoid hemorrhage: a Nationwide Inpatient Sample study. World Neurosurg 82:e235\u2013e241, 2014"},{"key":"b44-jns151107","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3171\/2014.4.JNS131100","article-title":"Analysis of subarachnoid hemorrhage using the Nationwide Inpatient Sample: the NIS-SAH Severity Score and Outcome Measure","volume":"121","author":"Washington CW,","year":"2014","unstructured":"Washington CW, Derdeyn CP, Dacey RG Jr, Dhar R, Zipfel GJ: Analysis of subarachnoid hemorrhage using the Nationwide Inpatient Sample: the NIS-SAH Severity Score and Outcome Measure. J Neurosurg 121:482\u2013489, 20142494967610.3171\/2014.4.JNS131100"},{"key":"b45-jns151107","series-title":"Arch Neurol","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/archneur.56.9.1087","article-title":"Dipyridamole plus aspirin in cerebrovascular disease","volume":"56","author":"Wilterdink JL,","year":"1999","unstructured":"Wilterdink JL, Easton JD: Dipyridamole plus aspirin in cerebrovascular disease. Arch Neurol 56:1087\u20131092, 199910.1001\/archneur.56.9.108710488809"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/126\/2\/article-p537.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/126\/2\/article-p537.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/126\/2\/article-p537.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T23:03:56Z","timestamp":1742684636000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/126\/2\/article-p537.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":45,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2015.12.jns151107","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}